The Effect of N115 on Coughing in IPF Patients
Phase 3
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Other: Saline Placebo control nasal sprayDrug: 20mM sodium pyruvate nasal spray
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Cellular Sciences, inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06037408
- Locations
- ๐บ๐ธ
Family First Medical Research Center, Hialeah Gardens, Florida, United States
Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.
Phase 2
Completed
- Conditions
- Long COVID
- Interventions
- Drug: sodium pyruvate nasal spray
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Cellular Sciences, inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04871815
- Locations
- ๐บ๐ธ
Missouri State University, Springfield, Missouri, United States
Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Cellular Sciences, inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04824365
- Locations
- ๐บ๐ธ
Family First Medical Research Center, Virginia Gardens, Florida, United States
๐บ๐ธMissouri State University, Springfield, Missouri, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath